Fleur COHEN AUBART
Internal Medicine Department 2 - Hôpital Pitié-Salpêtrière · APHP - Hôpital Pitié-Salpêtriere, Paris,France · Assistance Publique - Hôpitaux de Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fleur COHEN AUBART as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:54 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05689879 · Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in SarcoidosisAssistance Publique - Hôpitaux de Paris · active not recruiting · Sarcoidosis · study director
- Ph3NCT03704610 · Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)Assistance Publique - Hôpitaux de Paris · completed · Extrathoracic Sarcoidosis · study director
- Ph2/Ph3NCT03018834 · Anakinra Versus Placebo for the Treatment of Acute MyocarditISAssistance Publique - Hôpitaux de Paris · completed · Acute Myocarditis · principal investigator
- N/ANCT02089724 · Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester DiseaseGroupe Hospitalier Pitie-Salpetriere · unknown · Erdheim-Chester Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.